Ya-Ping Tu

2PUBLICATIONS
1CO-AUTHORS
Gene and molecular therapyFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 22, 2024
Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-α-positive ovarian cancer: Justification of therapeutic dose regimen.

Ya-Ping Tu, H Maxime Lagraauw, Michael Method

|Oct 23, 2023
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite.

Ya-Ping Tu, Eva Hanze, Fengying Zhu

Pageof 1

Frequent Collaborators

2 joint publications

H Maxime Lagraauw